Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

NCT04842604

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Landeskrankenhaus Salzburg, Universitatsklinik fur Innere Medizin III der PMU Salzburg, Austria
  • Uniklinikum Salzburg, Landeskrankenhaus Salzburg Salzburg, Austria
  • Health Sciences Centre Winnipeg, Manitoba, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 18 locations
View Trial Details
Completed

Empirical Versus Preemptive Antifungal Therapy

NCT01288378

Conditions
Bacterial Infections and Mycoses, Bone Marrow Diseases, Congenital Abnormalities, +12 more
Locations
  • A.Z. St. Jan Bruges, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
View all 16 locations
View Trial Details
Completed

Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT02543879

Conditions
Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations
  • Cedars Sinai Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Completed

A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

NCT02498665

Conditions
Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +67 more
Locations
  • USOR - Rocky Mountain Cancer Center Denver, Colorado, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Horizon Oncology Research Lafayette, Indiana, United States
  • USOR - TX Oncology Austin Austin, Texas, United States
View Trial Details
Completed

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

NCT02639559

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +38 more
Locations
  • Northside Hospital Cancer Institute Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details

Related conditions